Cantitate/Preț
Produs

Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Immunotherapy: Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, cartea 5

Editat de Kasuya Hideki, Itzel Bustos Villalobos
en Limba Engleză Hardback – 31 oct 2024
Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Immunotherapy discusses current and under investigation treatments in pancreatic cancer. The book presents information on how to combine current therapy with treatment under development and/or in clinical trials in order to improve survival. Chapters review new modalities to cure oncolytic viruses and Bi-specific T cell engager (BiTEs) as future clinical treatments, along with discussions on recent research using those modalities in combination therapy. The book is a valuable source for cancer researchers, oncologists and other members of the medical and biomedical field who are interested in learning more about new therapies.

  • Discusses oncolytic virus in pancreatic cancer use, mainly herpes and adenoviruses, the results obtained on basic research, and clinical trials
  • Encompasses knowledge on Bi-specific T cell engager (BiTEs), focusing on its function, development and use on pancreatic cancer
  • Brings information on recently developed combination therapies that allow for a lower dose of treatment and hence less side effects
Citește tot Restrânge

Din seria Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy

Preț: 79805 lei

Preț vechi: 103044 lei
-23% Nou

Puncte Express: 1197

Preț estimativ în valută:
15273 15865$ 12686£

Carte disponibilă

Livrare economică 06-20 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128229149
ISBN-10: 0128229144
Pagini: 250
Dimensiuni: 191 x 234 mm
Editura: ELSEVIER SCIENCE
Seria Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy


Cuprins

1. Pancreatic cancer generalities, current surgical treatment, updates
2. Current chemotherapy and immunotherapy in pancreatic cancer
3. Generalities of Oncolytic virus and HF10 in pancreatic cancer
4. Oncolytic Adenovirus use in pancreatic cancer
5. BiTE cell generalities and its potential use for pancreatic cancer
6. Precision oncology for pancreatic cancer
7. Strategies with immune therapy
8. Combination therapies of current/ new options to treat pancreatic cancer in future